Early studies in humans have shown that insulin-stimulated vasodilation could be a significant contributor to insulin-stimulated glucose uptake [103] by a mechanism involving eNOS, which can be impaired in people with obesity or type 2 diabetes [104]. Here, INS is linked to type 2 diabetes mellitus.